123 related articles for article (PubMed ID: 8526352)
1. Effect of retinoic acid (RA) in MNU-induced rat mammary tumors.
Okamoto T; Fujimoto N; Gotoh T; Ito A
Ann N Y Acad Sci; 1995 Sep; 768():223-6. PubMed ID: 8526352
[No Abstract] [Full Text] [Related]
2. Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid.
Teplitzky SR; Kiefer TL; Cheng Q; Dwivedi PD; Moroz K; Myers L; Anderson MB; Collins A; Dai J; Yuan L; Spriggs LL; Blask DE; Hill SM
Cancer Lett; 2001 Jul; 168(2):155-63. PubMed ID: 11403920
[TBL] [Abstract][Full Text] [Related]
3. Melatonin and 9-cis-retinoic acid in the chemoprevention of NMU-induced rat mammary carcinoma.
Teplitzky SR; Blask DE; Cheng Q; Myers L; Hill SM
Adv Exp Med Biol; 1999; 460():363-7. PubMed ID: 10810533
[No Abstract] [Full Text] [Related]
4. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effects of the aromatase inhibitors vorozole (R-83842) and 4-hydroxyandrostenedione in the methylnitrosourea (MNU)-induced mammary tumor model in Sprague-Dawley rats.
Lubet RA; Steele VE; Casebolt TL; Eto I; Kelloff GJ; Grubbs CJ
Carcinogenesis; 1994 Dec; 15(12):2775-80. PubMed ID: 8001234
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy.
Lacroix A; Doskas C; Bhat PV
Cancer Res; 1990 Sep; 50(18):5731-4. PubMed ID: 2393847
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
[TBL] [Abstract][Full Text] [Related]
8. Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically Induced Cancers.
Lubet RA; Heckman-Stoddard BM; Fox JT; Moeinpour F; Juliana MM; Shoemaker RH; Grubbs CJ
Cancer Prev Res (Phila); 2020 Mar; 13(3):283-290. PubMed ID: 31871222
[TBL] [Abstract][Full Text] [Related]
9. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the protective effects of 17beta-estradiol, biochanin A and bisphenol A on mammary gland differentiation and tumorigenesis in rats.
Yin H; Ito A; Bhattacharjee D; Hoshi M
Indian J Exp Biol; 2006 Jul; 44(7):540-6. PubMed ID: 16872042
[TBL] [Abstract][Full Text] [Related]
11. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
[TBL] [Abstract][Full Text] [Related]
12. Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland.
McCormick DL; Rao KV; Johnson WD; Bowman-Gram TA; Steele VE; Lubet RA; Kellof GJ
Cancer Res; 1996 Apr; 56(8):1724-6. PubMed ID: 8620482
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.
Lubet RA; Steele VE; DeCoster R; Bowden C; You M; Juliana MM; Eto I; Kelloff GJ; Grubbs CJ
Carcinogenesis; 1998 Aug; 19(8):1345-51. PubMed ID: 9744527
[TBL] [Abstract][Full Text] [Related]
14. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.
Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A.
Gotoh T; Yamada K; Yin H; Ito A; Kataoka T; Dohi K
Jpn J Cancer Res; 1998 Feb; 89(2):137-42. PubMed ID: 9548440
[TBL] [Abstract][Full Text] [Related]
16. Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis.
Crist KA; Wang Y; Lubet RA; Steele VE; Kelloff GJ; You M
J Cell Biochem Suppl; 1997; 27():92-9. PubMed ID: 9591198
[TBL] [Abstract][Full Text] [Related]
17. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
Welsch CW; Brown CK; Goodrich-Smith M; Chiusano J; Moon RC
Cancer Res; 1980 Sep; 40(9):3095-8. PubMed ID: 6893571
[TBL] [Abstract][Full Text] [Related]
19. Effect of D,L-2-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea.
Thompson HJ; Ronan AM
Carcinogenesis; 1986 Dec; 7(12):2003-6. PubMed ID: 3096587
[TBL] [Abstract][Full Text] [Related]
20. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
